Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic Investigation of Naltrexone in Smokers
NCT00270231Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Mar 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in tobacco dependence, sponsored by University of Pennsylvania. Started Mar 2004; status: completed.
02
Drugs
naltrexone
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT00270231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270231.